immunization schedule

Summary

Summary: Schedule giving optimum times usually for primary and/or secondary immunization.

Webpages

  1. adult health advisor index: 1 to b
    rpweb.uams.edu/CRS/AHA/AHA_index.htm
  2. immunization resources
    cchs-dl.slis.ua.edu/prevmedicine/immunization/general.htm
  3. medical library | medem.com
    www.medem.com/MedLB/article_detaillb.cfm?article_ID=ZZZV5AZL ...
  4. saskatchewan health - immunization schedule
    library.usask.ca/gp/sk/h/immunizationschedule05/www.health.g ...
  5. hepatitis b vaccine
    www.who.int/vaccines/en/hepatitisb.shtml
  6. septicemia
    www.clarian.org/ADAM/doc/HealthIllustratedEncyclopedia/1/001 ...
  7. recommended adult immunization schedule --- united states, october 2004--september 2005
    www.cdc.gov/MMWR/preview/mmwrhtml/mm5345-Immunizationa1.htm
  8. immunization schedule
    buchta.lib.bioinfo.pl/meid:28355
  9. acp: adult immunization initiative
    www.acponline.org/running_practice/quality_improvement/proje ...
  10. university public schools - enrollment
    universitypublicschools.asu.edu/enrollment/req_info.html

Research Grants

  1. The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations
    Carlos G Grijalva; Fiscal Year: 2008
  2. The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations
    Carlos G Grijalva; Fiscal Year: 2007
  3. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula J Lum; Fiscal Year: 2005
  4. Clinical Research and Mentoring in Epidemiology of Bacterial Diseases
    Lee H Harrison; Fiscal Year: 2008
  5. Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
    GEORGE S HUI; Fiscal Year: 2008
  6. BioThrax Schedule Optimization for Post-Exposure Prophylaxis of Anthrax
    ROBERT JAY HOPKINS; Fiscal Year: 2006
  7. Generation of antibodies by genetic immunization
    Hans Herweijer; Fiscal Year: 2002
  8. Therapeutic Immunization in Humans
    Julianna Lisziewicz; Fiscal Year: 2003

Publications

  1. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America
    Miguel Tregnaghi
    Centro de Desarrollo de Proyectos Avanzados, Córdoba, Argentina
    Rev Panam Salud Publica 19:179-88
  2. Combination vaccine use and vaccination quality in a managed care population
    Laura E Happe
    Xcenda, Palm Harbor, FL 34685, USA
    Am J Manag Care 13:506-12
  3. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants
    S Koltan
    Department of Paediatric Haematology and Oncology, Collegium Medicum, University of Nicolaus Copernicus, ul. Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland
    J Hosp Infect 60:73-7
  4. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations
    Tina Tan
    Division of Infectious Diseases, Northwestern University s Feinberg School of Medicine, The Children s Memorial Hospital, Chicago, IL 60614, USA
    Pediatr Infect Dis J 24:S83-6
  5. Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children's Memorial Hospital, 2300 Children's Plaza, Box 20, Chicago, IL 60614-3394, USA
    Pediatr Infect Dis J 24:S10-8
  6. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life
    Salvacion Gatchalian
    Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
    Hum Vaccin 4:60-6
  7. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization
    Robert L Davis
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98195, USA
    Pediatr Infect Dis J 22:657-8
  8. Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy
    Rose Marie Carlsson
    Department of Infectious Diseases, Sahlgrenska University Hospital Ostra, Göteborg, Sweden
    Pediatr Infect Dis J 21:535-41
  9. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine
    T Nolan
    Murdoch Children s Research Institute, The University of Melbourne, VIC 3010, Australia
    Vaccine 23:14-20
  10. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine
    Sirli Meriste
    Department of Infectious Diseases, Children s Clinic of Tartu University Hospital, Tartu, Estonia
    Scand J Infect Dis 38:350-6

Scientific Experts

Detail Information

Webpages77 found, 30 most recent shown here

  1. adult health advisor index: 1 to b
    rpweb.uams.edu/CRS/AHA/AHA_index.htm
  2. immunization resources
    cchs-dl.slis.ua.edu/prevmedicine/immunization/general.htm
  3. medical library | medem.com
    www.medem.com/MedLB/article_detaillb.cfm?article_ID=ZZZV5AZL ...
  4. saskatchewan health - immunization schedule
    library.usask.ca/gp/sk/h/immunizationschedule05/www.health.g ...
  5. hepatitis b vaccine
    www.who.int/vaccines/en/hepatitisb.shtml
  6. septicemia
    www.clarian.org/ADAM/doc/HealthIllustratedEncyclopedia/1/001 ...
  7. recommended adult immunization schedule --- united states, october 2004--september 2005
    www.cdc.gov/MMWR/preview/mmwrhtml/mm5345-Immunizationa1.htm
  8. immunization schedule
    buchta.lib.bioinfo.pl/meid:28355
  9. acp: adult immunization initiative
    www.acponline.org/running_practice/quality_improvement/proje ...
  10. university public schools - enrollment
    universitypublicschools.asu.edu/enrollment/req_info.html
  11. notice to readers diphtheria-tetanus-pertussis vaccine shortage
    www.cdc.gov/MMWR/preview/mmwrhtml/00000491.htm
  12. no title
    health.state.ga.us/programs/immunization/
  13. women's health advisor index: a to c
    www.fairview.org/healthlibrary/content/print_wha_index.htm
  14. the section of epidemiology, alaska immunization program
    www.epi.alaska.gov/id/immune.stm
  15. aap children's health topics: immunizations/vaccines
    www.aap.org/healthtopics/immunizations.cfm
  16. notice to readers recommended childhood immunization schedule -- united states, 1997
    www.cdc.gov/MMWR/preview/mmwrhtml/00046715.htm
  17. notice to readers recommended childhood immunization schedule -- united states, 1998
    www.cdc.gov/MMWR/preview/mmwrhtml/00053300.htm
  18. greenville hospital system
    www.ghs.org/HealthContent.aspx?id=73208
  19. brochures / forms / permits
    www.tchd.org/brochures.html
  20. health | child health | children's immunization schedule
    fcs.tamu.edu/health/child_health/immunizations/immunizations ...
  21. immunization and vaccination information from st. john health
    www.stjohn.org/Services/Immunizations/index.html
  22. aap issues recommended 2006 immunization schedule
    www.aap.org/advocacy/releases/jan06immsch.htm
  23. maine.gov: family & home: children's services
    www.maine.gov/portal/family/children.html
  24. immunization: medlineplus
    www.nlm.nih.gov/medlineplus/immunization.html
  25. notice to readers: fda approval of diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, (infanrix®) for fifth consecutive dtap vaccine dose
    www.cdc.gov/MMWR/preview/mmwrhtml/mm5238a9.htm
  26. aap - featured items archive
    www.aap.org/featuredarchive/index.html

Research Grants8

  1. The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations
    Carlos G Grijalva; Fiscal Year: 2008
    ..S. infant immunization schedule. Post-licensure surveillance has shown dramatic reductions in rates of invasive disease in vaccinated ..
  2. The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations
    Carlos G Grijalva; Fiscal Year: 2007
    ..S. infant immunization schedule. Post-licensure surveillance has shown dramatic reductions in rates of invasive disease in vaccinated ..
  3. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula J Lum; Fiscal Year: 2005
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  4. Clinical Research and Mentoring in Epidemiology of Bacterial Diseases
    Lee H Harrison; Fiscal Year: 2008
    ..in Brazil and provide policy makers with information for informed decisions about incorporation of new conjugate vaccines into the Brazilian immunization schedule. Public Health Relevance: This Public Health Relevance is not available.
  5. Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
    GEORGE S HUI; Fiscal Year: 2008
    ..regimens to efficiently induce protective antibodies under the more favorable logistics of a reduced immunization schedule and the use of readily acceptable adjuvants...
  6. BioThrax Schedule Optimization for Post-Exposure Prophylaxis of Anthrax
    ROBERT JAY HOPKINS; Fiscal Year: 2006
    ..This phase 3b clinical trial, Safety, Immunogenicity, and Immunization Schedule Study of Post-Exposure Prophylaxis for BioThrax(r) in a Population of Healthy Adults, will evaluate the ..
  7. Generation of antibodies by genetic immunization
    Hans Herweijer; Fiscal Year: 2002
    ..studies, we will further optimize genetic immunization methods by including cytokine genes, refining the immunization schedule, and testing different expression vectors and mouse strains...
  8. Therapeutic Immunization in Humans
    Julianna Lisziewicz; Fiscal Year: 2003
    ..The study is aimed to determine whether a one immunization schedule could replace and improve the two consecutive immunization schedule originally administered in the monkey ..

Publications62

  1. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America
    Miguel Tregnaghi
    Centro de Desarrollo de Proyectos Avanzados, Córdoba, Argentina
    Rev Panam Salud Publica 19:179-88
    ..CONCLUSIONS: Our results indicate that the new DTPw-HB/Hib pentavalent combination vaccine provides an efficient and reliable way of implementing WHO recommendations for controlling hepatitis B and Hib infections on a worldwide basis...
  2. Combination vaccine use and vaccination quality in a managed care population
    Laura E Happe
    Xcenda, Palm Harbor, FL 34685, USA
    Am J Manag Care 13:506-12
    ..5% (324/865) of the reference cohort, P = .001. CONCLUSIONS: Receipt of DTaP/HepB/IPV was associated with improved coverage and age-appropriate immunization in a managed care population...
  3. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants
    S Koltan
    Department of Paediatric Haematology and Oncology, Collegium Medicum, University of Nicolaus Copernicus, ul. Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland
    J Hosp Infect 60:73-7
    ..In children with cancer vaccinated against HBV according to the vaccination schedule, the immune response maintains a protective level of anti-HBs in more than 60% of cases, despite immunosuppression...
  4. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations
    Tina Tan
    Division of Infectious Diseases, Northwestern University s Feinberg School of Medicine, The Children s Memorial Hospital, Chicago, IL 60614, USA
    Pediatr Infect Dis J 24:S83-6
    ....
  5. Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children's Memorial Hospital, 2300 Children's Plaza, Box 20, Chicago, IL 60614-3394, USA
    Pediatr Infect Dis J 24:S10-8
    ..Understanding the link between these observations may lead to better informed global control strategies, especially those pertaining to immunization schedules and use of pertussis vaccine...
  6. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life
    Salvacion Gatchalian
    Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
    Hum Vaccin 4:60-6
    ..Combined DTPw-HBV and DTPw-HBV/Hib vaccines using new vaccine antigen sources will promote continued supply of combined DTPw-based vaccines to global mass vaccination campaigns...
  7. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization
    Robert L Davis
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98195, USA
    Pediatr Infect Dis J 22:657-8
    ..We evaluated the effect of introduction of a combined hepatitis B-Haemophilus influenzae b vaccine on vaccine coverage rates in a large health maintenance organization and found a modest improvement in up-to-date immunization status...
  8. Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy
    Rose Marie Carlsson
    Department of Infectious Diseases, Sahlgrenska University Hospital Ostra, Göteborg, Sweden
    Pediatr Infect Dis J 21:535-41
    ..CONCLUSION: We found the persistence of antibodies satisfactory, with no clinically relevant differences in antibody concentrations demonstrated between children vaccinated according to a three dose or a four dose schedule in infancy...
  9. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine
    T Nolan
    Murdoch Children s Research Institute, The University of Melbourne, VIC 3010, Australia
    Vaccine 23:14-20
    ..5% of booster recipients experienced >50-mm local swelling at the site of DTPa vaccination. We conclude that DTPa-HBV-IPV/Hib is safe and immunogenic for primary vaccination, and that Hib-specific memory is induced by primary vaccination...
  10. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine
    Sirli Meriste
    Department of Infectious Diseases, Children s Clinic of Tartu University Hospital, Tartu, Estonia
    Scand J Infect Dis 38:350-6
    ..Both vaccine regimens were well tolerated and immunogenic, however the combined administration has the advantage of being administered as a single injection...
  11. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants
    C Olivier
    Hôpital L Mourier, Colombes, France
    Vaccine 26:3142-52
    ..In this study, PCV7 did not show any relevant influence on the immunogenicity and safety of the concurrently administered DTPa-IPV-HBV-Hib vaccine...
  12. [Inoculation rates of children starting school in Bavaria]
    Gabriele Morlock
    Sachgebiet Public Health GE 4, Oberschleissheim
    MMW Fortschr Med 147:41, 43-4
    ..All physicians in private practice should therefore take every opportunity to check and document vaccination status, and, where necessary, update it...
  13. Postlicensure epidemiology of childhood vaccination: the Danish experience
    Anders Hviid
    Statens Serum Institut, Department of Epidemiology Research, Artillerivej 5, 2300 Copenhagen S, Denmark
    Expert Rev Vaccines 5:641-9
    ....
  14. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations
    Kevin Forsyth
    Department of Paediatrics, Flinders Medical Centre, Flinders University, Adelaide, Australia
    Pediatr Infect Dis J 24:S93-7
    ....
  15. The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine
    H J Schmitt
    Pediatric Infectious Diseases, Johannes Gutenberg University, Langenbeckstr 1, D 55101 Mainz, Germany
    Vaccine 21:3653-62
    ....
  16. Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine
    Stephen K Obaro
    Imperial College School of Medicine, London, United Kingdom
    Pediatr Infect Dis J 21:940-7
    ..77, 7.68 in the control group; 5.15 IU/ml, 95% CI 4.39, 6.03 in the combined group; P= 0.02). However, all vaccinees achieved protective antibody values. CONCLUSION: The combination of TETRAMUNE and PnCV is safe and immunogenic...
  17. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?
    Fernando de la Hoz
    Instituto Nacional de Salud de Colombia, Universidad Nacional de Colombia, Bogotá, Colombia
    Trop Med Int Health 10:322-9
    ..However, barriers to vaccination arise from inequities in the distribution of health insurance and inadequate HW knowledge...
  18. Control of varicella: why is a two-dose schedule necessary?
    Ann Arvin
    Stanford Medical School, Department of Pediatrics, Stanford, CA, USA
    Pediatr Infect Dis J 25:475-6
  19. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses
    Young Mo Sohn
    Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea
    Vaccine 26:1638-43
    ..However, further studies should be carried out to support whether one dose of live JE vaccine is sufficient for people in JE non-endemic area...
  20. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content
    Soju Chang
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U S Food and Drug Administration, Rockville, MD 20852, USA
    Pediatr Infect Dis J 26:329-33
    ..S. childhood immunization schedule, of vaccinations during the first 2 years of life...
  21. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine
    Irmingard Tichmann-Schumann
    Medical Practice, Munich, Germany
    Pediatr Infect Dis J 24:70-7
    ..8% of the booster vaccine doses. CONCLUSION: Coadministration of the DTPa-HBV-IPV/Hib and 7vPn vaccines at separate injection sites during the same vaccination visit was effective and safe...
  22. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children
    D Lehmann
    Papua New Guinea Institute of Medical Research, Goroka
    P N G Med J 44:6-16
    ..The liquid DTP/PRP-T formulation showed a lower immunogenicity than in earlier studies with this vaccine, which might have been due to exposure to low temperature during shipment or the younger age at immunization...
  23. Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines
    Roman Prymula
    University of Defense, Department of Epidemiology, Faculty of Military Health Science, Hradec Kralove, Czech Republic
    Expert Opin Biol Ther 8:503-13
    ..CONCLUSION: New antigen sources and reduced PRP will ensure the continued supply of DTPw-based combination vaccines for vital global mass vaccination campaigns...
  24. Measles immunization in Saudi Arabia: the need for change
    M K Khalil
    Medical Education and Research Centre, King Fahad Specialist Hospital, Buraidah, Saudi Arabia
    East Mediterr Health J 7:829-34
    ..The recent measles-mumps-rubella school campaign is also described...
  25. The use of combination vaccines has improved timeliness of vaccination in children
    Helen Kalies
    Department of Pediatric Epidemiology, Institute for Social Pediatrics and Adolescent Medicine of Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 25:507-12
    ..CONCLUSION: Combination vaccines are usually advocated for reducing the number of injections. In Germany, however, the use of combination vaccines has also significantly improved timeliness of immunizations...
  26. [A special immunization clinic tailors vaccinations]
    Bernice Aronsson
    Sachsska barnsjukhuset, Södersjukhuset, Stockholm
    Lakartidningen 105:1675-9
  27. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma]
    Rong-cheng Li
    Center for Disease Prevention and Control, Guangxi Zhuangzu Autonimous Region, Nanning 530021, China
    Zhonghua Liu Xing Bing Xue Za Zhi 25:385-7
    ..8% decrease, in the group of 0 - 19 year-olds. CONCLUSION: The universal infant hepatitis B vaccination has proved to be effective in reducing the incidence rate of acute hepatitis B as well as the mortality of hepatocellular carcinoma...
  28. [Hepatitis B vaccine prevention of the non-newborn populations in Beijing area]
    Yu-lan Xing
    Zhonghua Liu Xing Bing Xue Za Zhi 25:381-4
  29. Recombivax-HB: perspectives past, present and future
    Charmaine Venters
    Louisiana State University Health Sciences Center, Louisiana State University Health Sciences Center, Earl K Long Hospital, Department of Pediatrics, 5828 Airline Highway, Baton Rouge, LA 70805, USA
    Expert Rev Vaccines 3:119-29
    ..The incorporation of the vaccine into the infant and childhood immunization schedule has led to a decrease in the number of new hepatitis B cases reported each year, and there has been a ..
  30. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine
    Michael E Pichichero
    University of Rochester Medical Center, Rochester, New York 14642, USA
    J Pediatr 151:43-9, 49.e1-2
    ..No group differences were observed in rates of symptoms for which parents sought medical advice. CONCLUSIONS: DTaP-HepB-IPV was highly immunogenic and well tolerated when coadministered with Hib and PCV-7 at 2, 4, and 6 months of age...
  31. Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX and placebo versus PedvaxHIB and RECOMBIVAX HB in healthy infants
    Karen M Kaplan
    Merck and Co Inc, PO Box 4, BL 1 7, West Point, PA 19486, USA
    Vaccine 21:181-7
    ....
  32. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth
    Salvacion Gatchalian
    Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
    Hum Vaccin 1:198-203
    ..A birth dose of HBV is important to maximize protection against hepatitis B in endemic regions where the EPI schedule is in place...
  33. Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinations
    Jo Southern
    Immunisation Department, Centre for Infections, Health Protection Agency, Colindale, London, UK
    Hum Vaccin 2:237-42
    ..CONCLUSION: MCC vaccines can be given under the above schedules and safely in the presence of raised diphtheria and tetanus antibody levels without materially altering reactogenicity profiles of either vaccine...
  34. Hepatitis B vaccination in prisons
    Niyi Awofeso
    New South Wales Corrections Health Service, Population Health Unit, PO Box 150, Matraville, New South Wales 2036, Australia
    Bull World Health Organ 80:569-74
    ..A higher reference level for inferring adequate immunization is also recommended, with booster injections for inmates who do not meet the higher reference after a primary course of vaccination...
  35. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA, USA
    Expert Rev Vaccines 4:793-805
    ..In published studies, the safety, immunogenicity and effectiveness of this combination vaccine were comparable with those of separately administered vaccines, with the advantage of a simplified dosing schedule...
  36. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia
    Simonetta Viviani
    Gambia Hepatitis Intervention Study, International Agency for Research on Cancer WHO, Lyon, France
    Trop Med Int Health 9:1044-9
    ..Besides the maintenance of high vaccine coverage in infants and young children, booster doses of some of the EPI vaccines in adolescents should be considered...
  37. Live virus vaccination near a pregnancy: flawed policies, tragic results
    F Edward Yazbak
    TL Autism Research, West Falmouth, Massachusetts 02574 0770, USA
    Med Hypotheses 59:283-8
    ..Re-vaccination often fails to produce immunity, the very reason for which it was recommended...
  38. 10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia)
    Alain Berlioz Arthaud
    Institut Pasteur de Nouvelle Calédonie, 12 rue Paul Doumer, BP 61, 98845 Nouméa Cedex, New Caledonia
    Vaccine 21:2737-42
    ..Hepatitis B eradication could be achieved in New Caledonia by starting immunisation at birth, and by implementing a global catch-up program among preadolescents...
  39. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study
    Peter Aaby
    Bandim Health Project, Bissau, Guinea Bissau
    Pediatr Infect Dis J 22:798-805
    ..This nonspecific beneficial effect was particularly strong for girls. Further studies are needed to examine the extent of nonspecific effects in settings with high mortality...
  40. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted
    Alejandro Ellis
    Secretariat of Health of the City of Buenos Aires, Buenos Aires, Argentina
    Rev Panam Salud Publica 21:345-56
    ..CONCLUSIONS: Greater health gains are derived from the first than second hepatitis A vaccine dose. However, this analysis supports the cost-effectiveness of providing both first and second doses to Argentina's children...
  41. [Vaccinations for the travellers]
    Dominique Gendrel
    Service de pédiatrie, pathologie infectieuse et tropicale, Hôpital Cochin Saint Vincent de Paul, 75014 Paris
    Rev Prat 54:519-25
    ..In central Europe, tick-borne encephalitis vaccination is recommended for patients travelling in forest areas during spring and summer...
  42. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Scott A Halperin
    Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatr Infect Dis J 25:195-200
    ..CONCLUSION: Although there is a slight increase in injection site events with decreasing interval since a previous immunization, Tdap can be safely administered at intervals of > or = 18 months since a previous TD/Td vaccine...
  43. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia
    Swee Lan Wong
    Pediatric Department, Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia
    Southeast Asian J Trop Med Public Health 39:474-83
    ..Use of the combined DTPw-HBV/Hib vaccine can reduce the required number of injections from nine to four in the first few months of life...
  44. [The spread of the wild Poliovirus in the rural environment, the case of the Adzopé health district, Côte d'Ivoire]
    C G Akoua Koffi
    Laboratoire des Entérovirus, Institut Pasteur de Côte d Ivoire, BP 490 Abidjan 01, Côte D Ivoire
    Bull Soc Pathol Exot 97:87-90
    ..Moreover, OPV strains are well-known to revert to pathogenicity in vaccinees, therefore, the long term excretion of pathogenic OPV derived strains by a certain amount of vaccinees needs to be considered quite seriously...
  45. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine
    Heng Kock Cheng
    KK Women's and Children Hospital, Singapore
    Southeast Asian J Trop Med Public Health 35:685-92
    ..5 degrees C, in the DTPa HBV- IPV-Hib group (50% of vaccinees)...
  46. Immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type B conjugate vaccine (PRP-T) for primary and booster vaccinations
    Humberto Bracco Neto
    Department of Pediatrics, Federal University of São Paulo, Rua Correa de Lemos 780, São Paulo, SP, Brazil
    Braz J Infect Dis 9:363-73
    ..No interference with antibody response was evident. The vaccines provided high immunogenicity, following both the primary vaccinations and the booster dose...
  47. Optimization of foot-and-mouth disease vaccination protocols by surveillance of neutralization antibodies
    W B Chung
    Department of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung, Taiwan, ROC
    Vaccine 20:2665-70
    ..To achieve an efficient response to the FMD vaccine for piglets born to well vaccinated sows, vaccination need to be delayed until 10-12 weeks of ages for the first immunization, followed by a boost 4 weeks later...
  48. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination
    Martin O C Ota
    Medical Research Council Laboratories, Banjul, The Gambia
    J Immunol 168:919-25
    ..These results demonstrate that BCG influences the immune response to unrelated Ags in early life, likely through its influence on the maturation of dendritic cells...
  49. [Prevention of viral hepatitis]
    Miguel Bruguera
    Servicio de Hepatología, Hospital Clínic de Barcelona y Departamento de Medicina, Universidad de Barcelona, España
    Enferm Infecc Microbiol Clin 24:649-56
    ..Post-transfusion hepatitis has been virtually eradicated, but considerable effort is still needed to prevent nosocomial hepatitis...
  50. Simultaneous vaccination in Japanese travelers
    Yasutaka Mizuno
    Travel Clinic, Disease Control and Prevention Center, International Medical Center of Japan, Tokyo 162 8655, Japan
    Travel Med Infect Dis 5:85-9
    ..Provision of a simultaneous vaccination schedule should motivate more Japanese travelers to obtain immunizations and thereby reduce the risk of vaccine-preventable diseases...
  51. Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols
    N Linder
    Dept of Neonatology, Schneider Children s Medical Center of Israel, Petah Tiqva
    Infection 30:136-9
    ..5 years of age as compared to early-vaccinated preterm and full-term infants. The known short-term advantage of delayed vaccination of preterm infants was shown to persist for at least the first 3 years of life...
  52. Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated
    Angkool Kerdpanich
    Infectious Disease Unit, Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
    Int J Infect Dis 12:88-97
    ..CONCLUSION: Overall, the heptavalent and pentavalent vaccines had similar safety profiles. The difference observed in percentage of subjects with fever >39 degrees C did not lead to differences in medically attended visits for fever...
  53. Vaccine update: new CDC recommendations from 2007
    Doug Campos-Outcalt
    Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, USA
    J Fam Pract 57:181-4
  54. Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately
    R Saenger
    GlaxoSmithKline GmbH and Co KG, Theresienhoehe 11, 80339, Munich, Germany
    Vaccine 23:1135-43
    ..The hexavalent DTPa-HBV-IPV/Hib vaccine and the DTPa-IPV/Hib and HBV vaccines administered separately have similar good reactogenicity and safety profiles when given as booster doses in the second year of life...
  55. Do patients who fail to complete a hepatitis A or hepatitis B vaccination series have to restart it?
    Miriam J Alter
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Cleve Clin J Med 70:234
  56. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents
    Eric E Mast
    Division of Viral Hepatitis, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 54:1-31
    ..The second part of the ACIP statement, which will include updated recommendations and strategies to increase hepatitis B vaccination of adults, will be published separately...